Cannabiz editor-at-large Rhys Cohen unpacks the TGA’s decision to down schedule CBD.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

The Therapeutic Goods Administration (TGA) has confirmed that clinically-proven CBD products registered on the ARTG will be eligible for Schedule 3 over-the-counter sale at pharmacies at doses of up to 150mg per day as of February 1st 2021. 

Rhys Cohen

As well as being editor-at-large at Cannabiz, Rhys is the director of Cannabis Consulting Australia, which provides commercial consulting services to various domestic and international cannabis companies....